Heart Medical Europe BV

Heart Medical Europe BV is a specialized distributor and importer of medical products focused on interventional pediatric cardiology, interventional radiology, and cardiothoracic surgery, providing essential devices for high-precision surgical procedures. Heart Medical Europe BV operates as a distributor and importer of medical devices tailored for hospital use. Founded in the Netherlands, the company has established its headquarters there and has undertaken a strategic focus on specialized medical fields. The company received investment in January 2018, when TransEquity Network acquired a stake in it, although financial terms were not disclosed.

The company engaged in a total of one deal by this date. Heart Medical is a European ISO 13485:2016 certified distributor and importer specializing in medical products within the fields of interventional pediatric cardiology, interventional radiology, and cardiothoracic surgery. The company provides a comprehensive range of medical devices designed for use in hospital settings, particularly during surgical procedures requiring high precision and reliability. Key offerings include the Z-MED II™ dilatation catheter, which features a coaxial shaft design for enhanced strength and pushability, and various pediatric valvuloplasty catheters, which are essential for minimally invasive heart repair procedures.

Heart Medical serves a diverse clientele, including hospital systems, surgical centers, and healthcare professionals across the Benelux region, as well as other European markets. The company is focused on addressing the needs of specialists by ensuring access to high-quality medical devices that are critical for improving patient outcomes. Heart Medical generates revenue through various direct sales channels, primarily engaging with hospitals, surgical centers, and medical professionals. Transactions typically occur on a B2B basis, where healthcare providers purchase medical devices to facilitate surgical interventions.

The company structures its pricing around individual product offerings, which include specialized equipment such as the Z-MED II™ dilatation catheter and pediatric valvuloplasty catheters. These products are sold in individual packaging or sets, depending on the use case, and are supported by comprehensive product documentation, including Instructions for Use (IFU). Heart Medical's revenue model is rooted in establishing long-term relationships with its clients, ensuring they are equipped with the necessary tools to deliver high-quality patient care. Heart Medical is focused on developing and launching new medical products to enhance its portfolio in the interventional medical device market.

The company aims to expand its market presence in the Benelux region and other European countries by 2025. The investment from TransEquity Network will support these initiatives, allowing Heart Medical to bolster its product development efforts and enhance its sales capabilities.